SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-21-000462
Filing Date
2021-01-04
Accepted
2021-01-04 19:59:22
Documents
2
Period of Report
2021-01-01

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm211568-1_3seq1.html 3  
1 OWNERSHIP DOCUMENT tm211568-1_3seq1.xml 3 2838
2 EXHIBIT 24 tm211568d1_ex24.htm EX-24 8220
  Complete submission text file 0001104659-21-000462.txt   12587
Mailing Address 9715 KEY WEST AVENUE ROCKVILLE MD 20850
Business Address 9715 KEY WEST AVENUE ROCKVILLE MD 20850 301-838-2500
SUPERNUS PHARMACEUTICALS, INC. (Issuer) CIK: 0001356576 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O SUPERNUS PHARMACEUTICALS, INC. 9715 KEY WEST AVENUE ROCKVILLE MD 20850
Business Address 3018382500
Rubin Jonathan (Reporting) CIK: 0001836067 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-35518 | Film No.: 21503531